A Phase 2 Study of HB0017 in Psoriasis Patients

A Clinical Study of SHR-1314 Injection in the Treatment of Moderate to Severe Plaque Psoriasis in Adults

NCT04121143 ·Status: SUSPENDED ·Phase: PHASE2

A Phase 2 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis

NCT05604898 ·Status: UNKNOWN ·Phase: PHASE2

A Study to Confirm Efficacy and Safety of HS-10374 for Moderate to Severe Plaque Psoriasis

NCT06672393 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study of HS-20137 in Participants with Moderate-to-severe Plaque Psoriasis

NCT06844799 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)

NCT06231381 ·Status: RECRUITING ·Phase: PHASE2

A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis

NCT07150988 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

An Phase III Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With PsO

NCT06299982 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3

A Study of Switching to Picankibart in Chinese Patients With Plaque Psoriasis With an Inadequate Response to Interleukin-17 Monoclonal Antibody Therapy

NCT06945107 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

A Clinical Study to Evaluate the Efficacy and Safety of Subcutaneous JS005 Injection in the Treatment of Adults With Moderate to Severe Chronic Plaque Psoriasis

NCT05975268 ·Status: COMPLETED ·Phase: PHASE3

A Phase 3 Study of Recombinant Anti-IL-17A Humanized Monoclonal Antibody in Chinese Participants With Moderate-to-Severe Plaque Psoriasis

NCT05536726 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate IBI112 in the Treatment of Psoriasis With Moderate to Severe Plaque Psoriasis

NCT05645627 ·Status: COMPLETED ·Phase: PHASE3

To Evaluate the Efficacy and Safety of AK111 Injection in the Treatment of Moderate to Severe Plaque Psoriasis

NCT06061471 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerance, Efficacy and Pharmacokinetics of JS005 Multiple Dosing

NCT05344248 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Trial Comparing SHR-1139 Injection With Placebo in Patients With Moderate-to-severe Plaque Psoriasis

NCT06875934 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Safety Study of Multiple Subcutaneous (s.c.) Injections of SHR-1314 in Adults With Moderate-to-severe Plaque Psoriasis

NCT03710681 ·Status: UNKNOWN ·Phase: PHASE1

A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis

NCT06011733 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of HS-10374 Compared to Placebo in Adults With Active Psoriatic Arthritis

NCT06176508 ·Status: RECRUITING ·Phase: PHASE2

A Phase 4 Study of Brodalumab (KHK4827) in Subjects With Moderate to Severe Plaque Psoriasis

NCT04614298 ·Status: WITHDRAWN ·Phase: PHASE4

Multi-Dose Study of SHR-1314 in Subjects With Moderate-to-severe Plaque Psoriasis

NCT03463187 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

IBI112 in Moderate to Severe Plaque Psoriasis With Randomized Withdrawal and Re-treatment

NCT06049810 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Efficacy and Safety of LZM012

NCT06110676 ·Status: RECRUITING ·Phase: PHASE3

Randomized Double-Blind Placebo-Controlled Trial Using Recombinant Human Interleukin-10 for Moderate-to-Severe Psoriasis

NCT00001797 ·Status: COMPLETED ·Phase: PHASE2

Randomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy Subjects

NCT04367441 ·Status: UNKNOWN ·Phase: PHASE1

A Study of KHK4827 (Brodalumab) in Subjects With Moderate to Severe Psoriasis in Korea

NCT02982005 ·Status: COMPLETED ·Phase: PHASE3

Clinical Study of AK101 in Subjects With Moderate to Severe Plaque Psoriasis

NCT04173637 ·Status: COMPLETED ·Phase: PHASE2